[New perspectives in the treatment of hypertension]

J J Mourad1

  • 1Service de Médecine Interne, Hôpital Saint Michel, 33 rue Olivier de Serres, 75015 Paris.

Annales De Cardiologie Et D'Angeiologie
|January 31, 2003
PubMed

Insights

Fixed low-dose ACE inhibitor/diuretic combination therapy effectively controlled hypertension in patients over 65. This treatment demonstrated sustained blood pressure control and promising long-term patient compliance.

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Hypertension management in elderly patients presents unique challenges.
  • First-line treatment options for systolodiastolic and isolated systolic hypertension require evaluation for long-term efficacy and adherence.
  • The 18th "Journées de l'Hypertension" conference highlighted new research in antihypertensive therapies.

Purpose:

  • To evaluate the long-term efficacy and tolerability of fixed very low dose ACE inhibitor/diuretic bitherapy as a first-line treatment for hypertension in patients over 65.
  • To assess the sustained blood pressure control rates in patients with systolodiastolic hypertension and isolated systolic hypertension.
  • To compare the outcomes of this bitherapy with other first-line antihypertensive treatments.

Summary:

  • Two novel studies investigated fixed very low dose ACE inhibitor/diuretic bitherapy in hypertensive patients aged 65 and older.
  • 80% of patients achieved and maintained blood pressure control for 15 months, with dosage adjustments allowed if diastolic blood pressure exceeded 90 mmHg.
  • Similar positive outcomes were observed in patients with isolated systolic hypertension.

Impact:

  • This fixed low-dose bitherapy shows significant promise for improving long-term blood pressure management in the elderly population.
  • The findings suggest enhanced patient compliance and sustained therapeutic effects compared to existing first-line antihypertensive strategies.
  • This approach may offer a valuable new option for initiating hypertension treatment in older adults.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.